A guide to sexual changes after hysterectomy, covering libido shifts, orgasm changes, genitourinary syndrome of menopause, vaginismus, HSDD, and evidence-based treatment options.
A guide to post-SSRI sexual dysfunction in women, covering PSSD mechanisms, HSDD, female orgasmic disorder, GSM overlap, vaginismus, and evidence-based treatments including flibanserin, bupropion, PT-141, and hormone therapy.
PT-141 (bremelanotide) causes nausea in up to 40% of users and transient skin darkening in roughly 1 in 7 women. Learn the mechanisms, management strategies, and how Addyi's alcohol restriction compares.
No dose adjustment is needed for Zepbound in mild, moderate, or severe liver impairment. Standard titration from 2.5 mg weekly still applies, per PK study data.
Zepbound (tirzepatide) is not FDA-approved for children under 12. This clinical review covers the pediatric labeling gap, available safety data, growth monitoring concerns, and what families should do in 2025.
A clinician-level breakdown of Zepbound (tirzepatide) pharmacokinetics, covering absorption after subcutaneous injection, protein binding, metabolic pathways, half-life, and renal/hepatic excretion, with citations to FDA labeling, SURMOUNT-1, and primary PK studies.
A guide to switching between Zepbound (tirzepatide) and other weight-loss medications in the same class, including semaglutide, liraglutide, and oral GLP-1 agents. Covers mechanism, dosing bridging strategies, and clinical evidence.
A complete clinical guide to monitoring tirzepatide (Zepbound) in young adults aged 18, 29, covering labs, vitals, fertility, mental health, and dose-escalation checkpoints.
A clinician-oriented review of how Zepbound (tirzepatide) affects appetite, food cravings, and eating behavior, with attention to what is established by trial evidence versus what remains mechanistic hypothesis.
A guide to using Zepbound (tirzepatide) in patients with autoimmune disease, covering immunologic mechanisms, disease-specific risks, drug interactions, and monitoring questions clinicians should raise before prescribing.
A clinical deep-dive into how tirzepatide (Zepbound) affects bone mineral density, fracture risk, and bone turnover markers, with primary-literature citations and practical monitoring guidance.
A deep dive into tirzepatide's effects on cognition, brain inflammation, and neurological markers, with primary-literature citations and clinical guidance.
A clinician-level review of tirzepatide microdosing protocols for weight management, including SURMOUNT-1 data, off-label dose reduction strategies, tolerability evidence, and practical prescribing guidance.
A clinical deep-dive into tirzepatide (Zepbound) use after bariatric surgery, covering pharmacokinetics, dosing, safety, and the evidence base for post-bariatric GLP-1/GIP therapy.
Restarting Zepbound after food poisoning, COVID-19, or surgery: what changes the decision, why there is no fixed dose-step rule, and what to ask your prescriber.
A clinical deep-dive into zoledronic acid (Reclast) hair loss and skin reactions, covering incidence data, mechanisms, management, and when to escalate care.
A guide to zolpidem (Ambien) and its documented effects on hair and skin, including telogen effluvium, pruritus, urticaria, and angioedema, with primary-literature citations and dose-specific guidance.
A complete clinical guide for caregivers administering dulaglutide (Trulicity) to adults aged 65 and older, covering injection technique, dose timing, hypoglycemia risk, storage, and monitoring protocols reviewed by board-certified physicians.
A clinical review of tretinoin (topical retinoid) off-label use in children younger than 12, covering evidence, approved indications, safety data, dosing considerations, and when prescribers may consider it.
Tirzepatide (Zepbound) is not approved for children under 12. This guide covers what families, school nurses, and pediatricians need to know about GLP-1/GIP medications, physical activity, and school accommodations for young children with obesity.
How temperature, sweat, humidity, and seasonal vitamin D shifts affect AndroGel (testosterone gel 1% and 1.62%) absorption, dosing, and monitoring. Evidence-based guidance from the T-Trials and current Endocrine Society guidelines.
A clinical deep-dive into how SARMs suppress the hypothalamic-pituitary-gonadal axis, damage the liver, and stress the heart. Learn what the research actually says about dosing, recovery, and risk reduction.
An independent pricing analysis of Function Health's subscription model, lab panel value, and total annual cost versus alternatives. prepared by the HealthRX.com Editorial Team.
An evidence-based analysis of who Gennev is best suited for, what it prescribes, how much it costs, and how it compares to alternatives for managing menopause symptoms.
An independent, evidence-based synthesis of Midi Health patient outcomes, costs, prescribing patterns, and how the platform compares to alternatives for perimenopause and menopause care.
An evidence-based review of TrimRx, the compounded GLP-1 telehealth brand. Learn how it works, what it costs, how it compares to alternatives, and what the clinical evidence says about compounded semaglutide and tirzepatide.
A critical, evidence-based review of Alloy's LegitScript status, state medical board oversight, FDA compliance, BBB standing, and clinical legitimacy as a women's HRT telehealth provider.
An independent look at Alloy's medical leadership, clinical credentials, prescribing model, and safety record for women seeking menopause HRT online.
AG1 is not FDA-approved; it's regulated as a dietary supplement with proprietary blends and an open BBB complaint history as of early 2025.
Bosley charges $4 to $10 per graft for surgical hair restoration, with sessions running 1,000 to 3,500 grafts. See pricing trends and financing options.
An independent review of Evernow's LegitScript certification status, state licensing, BBB rating, FDA compliance, and complaint record for patients considering menopause telehealth care.
An independent breakdown of Gennev's pricing history, membership tiers, complaint patterns, and how the platform's costs and transparency compare with competitors, for editorial and medical review.
An evidence-based review of GoodRx's medical leadership, credentials, regulatory standing, and what independent sources say about its legitimacy as a prescription discount service.
An independent analysis of Happy Head BBB ratings, consumer complaint patterns, FDA compounding rules, and what the data means for patients considering compounded hair-loss treatment.
An independent review of Midi Health BBB ratings, consumer complaints, telehealth legitimacy, and what perimenopause patients should know before signing up.
An independent review of Midi Health's pricing history, insurance coverage, cash-pay rates, and how costs have shifted since 2021. Includes complaints, legitimacy check, and clinical context for menopause care.
An independent review of Prime Mind BBB complaints, consumer reports, FDA status, and LegitScript verification for this ADHD and cognition telehealth brand. Includes citation-dense analysis of regulatory standing and what patients should check before signing up.
An independent clinical review of Talkspace prescribing practices, outcomes data, complaint patterns, and platform legitimacy. Includes primary-source citations from FDA, state medical boards, and peer-reviewed research.
An independent review of Transcend's LegitScript certification status, state pharmacy board compliance, FDA regulatory standing, BBB record, and patient complaints for hormone therapy and peptide services.
A critical, evidence-based review of Transcend hormone clinic covering which patient profiles should avoid it, legitimacy concerns, complaint patterns, and what board-certified physicians look for before recommending a cash-pay telehealth provider.
A detailed, evidence-based look at Viome's medical leadership, scientific credentials, regulatory standing, and the clinical validity of its microbiome testing products.
An independent, evidence-based review of Winona's medical leadership, physician credentials, compounding pharmacy practices, and patient safety record for menopause HRT telehealth.
An independent review of Women's International Pharmacy pricing history, legitimacy, complaint record, regulatory standing, and how costs compare to alternatives for compounded BHRT.
An evidence-based, critical review of ZOE's medical leadership, scientific advisory board, published research, regulatory standing, and common complaints. Includes primary-source citations throughout.
A clinical and insurance guide to Anthem (Elevance Health) coverage of Vyleesi (bremelanotide) for HSDD, including prior authorization criteria, step therapy requirements, appeal strategies, and cost alternatives.
A clinician-level review of bremelanotide (Vyleesi) safety signals, FDA actions, post-marketing data, and the melanocortin mechanism behind HSDD treatment in premenopausal women.
A deep dive into bremelanotide (Vyleesi) and renal function: pharmacokinetics, clinical trial safety data, FDA labeling guidance, and practical prescribing advice for patients with kidney concerns.
A clinical-level review of GLP-1 receptor agonist use across special populations, pregnancy, renal impairment, heart failure, pediatrics, and more, with dosing guidance, trial data, and guideline citations.
Ipamorelin, sermorelin, CJC-1295, GHRP-6, and MK-677 compared by pulsatility, cortisol/prolactin effects, route, and goal to guide agent selection.
A detailed comparison of liraglutide 3 mg (Saxenda) and dulaglutide (Trulicity) side-effect profiles, drawn from SCALE, REWIND, and current prescribing guidelines.
A clinical comparison of tirzepatide (Zepbound) and liraglutide, covering efficacy data from SURMOUNT-1 and SCALE Obesity, practical switching protocols, and when each drug fits best.
A clinical comparison of vardenafil and alprostadil for erectile dysfunction: efficacy data, trial results, mechanism differences, and guidance on which drug fits which patient.
A direct comparison of BPC-157 pentadecapeptide and GHK-Cu copper tripeptide covering mechanism, evidence quality, dosing, cost, and legal access in 2025.
A detailed, citation-dense comparison of semaglutide (Ozempic) and tirzepatide (Mounjaro) drawing on head-to-head trials, large real-world cohorts, and current clinical guidelines to help you and your provider decide which GLP-1 therapy fits your situation.
A head-to-head clinical comparison of oral semaglutide (Rybelsus) and liraglutide on weight loss, glycemic control, and durability of response over 52 to 68 weeks, with guidance on switching.
A data-driven comparison of liraglutide 3 mg (Saxenda) and dulaglutide (Trulicity) for weight loss and cardiometabolic outcomes, drawing on SCALE, REWIND, and real-world cohort data.
A detailed clinical comparison of liraglutide 3 mg (Saxenda) and dulaglutide (Trulicity) across special populations including type 2 diabetes, obesity without diabetes, cardiovascular disease, CKD, older adults, and pregnancy considerations.
A clinical comparison of Wegovy (semaglutide 2.4 mg) and Saxenda (liraglutide 3 mg) titration schedules, side-effect profiles, weight-loss outcomes, and switching considerations, prepared by the HealthRX.com Editorial Team.
A clinical comparison of rapamycin (sirolimus) and NMN/NR (nicotinamide mononucleotide/riboside) for longevity, including how to recognize failure and when to switch or combine.
A clinical guide comparing enclomiphene citrate and Jatenzo (oral testosterone undecanoate) for male hypogonadism, with decision frameworks for switching when one therapy stops working.
LegitScript certification
Verify HealthRX.comHealthRX.com is a platform connecting patients with independent licensed healthcare providers and pharmacies. Those providers deliver medical care and pharmacies dispense medication. Prescriptions are issued only when clinically appropriate. Payment does not guarantee a prescription.
Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality. Individual results vary.
Website information is educational and is not a substitute for personalized medical advice, diagnosis, or treatment. Consult your licensed healthcare provider.